Neurologic Diseases and Neurogenetics

Summary

This group undertakes the challenges of developing advanced treatments for patients with movement disorders, refractory epilepsy, neuropathies, myasthenia, myopathies, etc., in addition to the work carried out with the Multiple Sclerosis Unit and the Multidisciplinary Unit for Patients with Amyotrophic Lateral Sclerosis (thanks to the collaboration with the Miquel Valls Foundation).he group works in the development of new diagnostic and prognostic biomarkers and clínical, epidemiological studies in neurologial diseases.

619

Publications

pyramidal_hippocampal_neuron_40x
Antonio-Martinez-Yelamos22

Martinez Yelamos, Antonio

Investigadores principales

Antonio-Martinez-Yelamos22

Martinez Yelamos, Antonio

avatar

Prat Rojo, Joan

Julia-Miro-Llado

Miró Lladó, Júlia

avatar

Gascón Bayarri, Jordi

Monica-Povedano-Panades

Povedano Panades, Mònica

Sergio-Martinez-Yelamos

Martinez Yelamos, Sergio

avatar

Calopa Garriga, Matilde

Lucia-Aja-Rodriguez

Aja Rodriguez, Lucia

Serge-Jauma-Classen

Jauma Classen, Serge

Pere-Cardona-Portela

Cardona Portela, Pere

Merce-Falip-Centellas

Falip Centellas, Mercedes

Team

Group Leaders
  • Martinez Yelamos, Antonio
Principal Investigators
Clinical Investigators
Predoctoral researchers
Scientific support
Management support
Scroll to Top